Kim Yeon Jin, Shin Sang Hyun, Han In Woong, Ryu Youngju, Kim Naru, Choi Dong Wook, Heo Jin Seok
Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):269-276. doi: 10.14701/ahbps.2020.24.3.269.
BACKGROUNDS/AIMS: The comparative effectiveness of pylorus-resecting pancreaticoduodenectomy (PRPD) and pylorus- preserving pancreaticoduodenectomy (PPPD) in pancreatic head cancer is still disputed. The aim of this study was to analyze the data obtained from a large, single center with PPPD compared with PRPD in terms of postoperative outcomes, including blood glucose levels and survival in patients with pancreatic head cancer.
Between January 2007 and December 2016, a total of 556 patients with pancreatic head cancer underwent either PPPD or PRPD. We analyzed the clinicopathologic data to assess short- and long-term outcomes retrospectively.
For underlying disease, patients with DM in PPPD were fewer than in PRPD (33.0% vs. 46.2%, =0.002). The median value of CA19-9 was significantly higher in PRPD than in PPPD (129.36 vs. 86.47, =0.037). The incidence of Clavien-Dindo grade III to V major complications in PPPD was significantly higher than in PRPD (20.4% vs. 13.4%, =0.032). Resection of pylorus was shown to reduce complications in univariate and multivariate analyses (=0.032 and = 0.021, respectively). The 5-year survival rates were 27.6% in the PPPD group and 22.4% in the PRPD group (=0.015).
The results of PPPD and PRPD showed no significant differences from those reported conventionally in previous studies. Although further well-designed studies are needed, it is more important to select the range of surgical resection for the patient's disease regardless of resection of pylorus.
背景/目的:幽门切除的胰十二指肠切除术(PRPD)与保留幽门的胰十二指肠切除术(PPPD)治疗胰头癌的相对疗效仍存在争议。本研究旨在分析来自一个大型单中心的数据,比较PPPD与PRPD在胰头癌患者术后结局方面的差异,包括血糖水平和生存率。
2007年1月至2016年12月期间,共有556例胰头癌患者接受了PPPD或PRPD。我们回顾性分析了临床病理数据以评估短期和长期结局。
就基础疾病而言,PPPD组糖尿病患者少于PRPD组(33.0%对46.2%,P=0.002)。PRPD组CA19-9的中位数显著高于PPPD组(129.36对86.47,P=0.037)。PPPD组Clavien-DindoⅢ至Ⅴ级严重并发症的发生率显著高于PRPD组(20.4%对13.4%,P=0.032)。单因素和多因素分析均显示,幽门切除可降低并发症发生率(分别为P=0.032和P=0.021)。PPPD组的5年生存率为27.6%,PRPD组为22.4%(P=0.015)。
PPPD和PRPD的结果与以往常规报道的结果无显著差异。尽管需要进一步设计完善的研究,但更重要的是根据患者病情选择手术切除范围,而不论是否切除幽门。